Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole pharmacokinetics in children and adolescents with invasive fungal infection
NL-OMON51517Phase 4Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole in invasive mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Population pharmacokinetic characterization of fluconazole, Fluconazole clearance and 4 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
fluconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on NL-OMON51517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51517.